Clinical Trial Update: Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study of capecitabine for women with advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Pharmatech Oncology | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN